Journal of Inflammation Research
Volume 14, 2021 - Issue
Open access
87
Views
9
CrossRef citations to date
0
Altmetric
Commentary
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
Youcui Wang1 Institute of Brain Science and Disease, Qingdao University, Qingdao, People’s Republic of China;2 Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, People’s Republic of China;3 Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao University, Qingdao, People’s Republic of ChinaView further author information
, Xiaoqin Zhang1 Institute of Brain Science and Disease, Qingdao University, Qingdao, People’s Republic of China;2 Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, People’s Republic of China;3 Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao University, Qingdao, People’s Republic of ChinaView further author information
, Fenghua Chen1 Institute of Brain Science and Disease, Qingdao University, Qingdao, People’s Republic of China;2 Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, People’s Republic of China;3 Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao University, Qingdao, People’s Republic of ChinaView further author information
, Leilei Chen1 Institute of Brain Science and Disease, Qingdao University, Qingdao, People’s Republic of China;2 Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, People’s Republic of China;3 Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao University, Qingdao, People’s Republic of ChinaView further author information
, Jun Wang1 Institute of Brain Science and Disease, Qingdao University, Qingdao, People’s Republic of China;2 Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, People’s Republic of China;3 Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao University, Qingdao, People’s Republic of ChinaView further author information
& Junxia Xie1 Institute of Brain Science and Disease, Qingdao University, Qingdao, People’s Republic of China;2 Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, People’s Republic of China;3 Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao University, Qingdao, People’s Republic of ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 2583-2586
|
Published online: 16 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.